Re: Nivolumab in Combination with Stereotactic Body Radiotherapy in Pretreated Patients with Metastatic Renal Cell Carcinoma. Results of the Phase II NIVES Study

Renal Cell ◽

Nivolumab in Combination with Stereotactic Body Radiotherapy in Pretreated Patients with Metastatic Renal Cell Carcinoma. Results of the Phase II NIVES Study

European Urology ◽

10.1016/j.eururo.2021.09.016 ◽

2021 ◽

Author(s):

Cristina Masini ◽

Cinzia Iotti ◽

Ugo De Giorgi ◽

Roberto Salvatore Bellia ◽

Sebastiano Buti ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Renal Cell ◽

Re: Cristina Masini, Cinzia Iotti, Ugo De Giorgi, et al. Nivolumab in Combination with Stereotactic Body Radiotherapy in Pretreated Patients with Metastatic Renal Cell Carcinoma. Results of the Phase II NIVES Study. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.09.016

European Urology ◽

10.1016/j.eururo.2021.11.034 ◽

2022 ◽

Author(s):

Giulio Francolini ◽

Lucia P. Ciccone ◽

Lorenzo Livi

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Renal Cell ◽

Re: Cristina Masini, Cinzia Iotti, Ugo De Giorgi, et al. Nivolumab in Combination with Stereotactic Body Radiotherapy in Pretreated Patients with Metastatic Renal Cell Carcinoma. Results of the Phase II NIVES Study. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.09.016

European Urology ◽

10.1016/j.eururo.2021.11.035 ◽

2022 ◽

Author(s):

Ye Lei ◽

Yong Zhang ◽

Nianzeng Xing

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Renal Cell ◽

NIVES study: A phase II trial of nivolumab (NIVO) plus stereotactic body radiotherapy (SBRT) in II and III line of patients (pts) with metastatic renal cell carcinoma (mRCC).

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.tps4602 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. TPS4602-TPS4602 ◽

Cited By ~ 1

Author(s):

Cristina Masini ◽

Cinzia Iotti ◽

Patrizia Ciammella ◽

Roberta Gnoni ◽

Annalisa Berselli ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Renal Cell ◽

Phase Ii Trial

Faculty Opinions recommendation of Phase II placebo-controlled randomized discontinuation trial of sorafenib in patients with metastatic renal cell carcinoma.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.14342.471834 ◽

2006 ◽

Author(s):

Robert Figlin

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Renal Cell ◽

Randomized Discontinuation Trial

RANDOMIZED PHASE II STUDY OF FIRST-LINE EVEROLIMUS (EVE) + BEVACIZUMAB (BEV) VERSUS INTERFERON ALFA-2A (IFN) + BEV IN PATIENTS (PTS) WITH METASTATIC RENAL CELL CARCINOMA (MRCC): RECORD-2

Annals of Oncology ◽

10.1093/annonc/mds399 ◽

2012 ◽

Vol 23 ◽

pp. ix258 ◽

Cited By ~ 24

Author(s):

A. Ravaud ◽

C. Barrios ◽

Ö. Anak ◽

D. Pelov ◽

A. Louveau ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Renal Cell ◽

Phase Ii Study ◽

Interferon Alfa ◽

First Line ◽

Randomized Phase Ii

Phase II Trial of Low Dose γ -Interferon in Metastatic Renal Cell Carcinoma

The Journal of Urology ◽

10.1016/s0022-5347(17)32587-9 ◽

1994 ◽

Vol 152 (3) ◽

pp. 841-845 ◽

Cited By ~ 32

Author(s):

Julie A. Ellerhorst ◽

Robert G. Kilbourn ◽

Robert J. Amato ◽

Alexander A. Zukiwski ◽

Elaine Jones ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Renal Cell ◽

Low Dose ◽

Phase Ii Trial ◽

Γ Interferon

Cyclic Interf eron Alpha Treatment in Metastatic Renal Cell Carcinoma: Results of a Phase II Study and Review of the Literature

Urologia Internationalis ◽

10.1159/000282937 ◽

1997 ◽

Vol 58 (1) ◽

pp. 8-12 ◽

Cited By ~ 4

Author(s):

Georg Hofmockel ◽

Winfried Tack ◽

Hubert G.W. Frohmüller

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Renal Cell ◽

Phase Ii Study ◽

Review Of The Literature

An early phase II trial of S-1 in Japanese patients with cytokine-refractory metastatic renal cell carcinoma

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-010-1262-8 ◽

2010 ◽

Vol 66 (6) ◽

pp. 1065-1070 ◽

Cited By ~ 6

Author(s):

Seiji Naito ◽

Taiji Tsukamoto ◽

Michiyuki Usami ◽

Hiroyuki Fujimoto ◽

Hideyuki Akaza

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Renal Cell ◽

Early Phase ◽

Phase Ii Trial ◽

Japanese Patients

A phase II trial of first-line sorafenib in patients with metastatic renal cell carcinoma unwilling to receive or with early intolerance to immunotherapy: SOGUG Study 06-01

Clinical & Translational Oncology ◽

10.1007/s12094-010-0544-2 ◽

2010 ◽

Vol 12 (7) ◽

pp. 503-508 ◽

Cited By ~ 9

Author(s):

Joaquim Bellmunt ◽

Pablo Maroto-Rey ◽

José M. Trigo ◽

Joan Carles ◽

Vicente Guillem ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Renal Cell ◽

Phase Ii Trial ◽

First Line ◽

To Receive